Organon & Co.
OGN
Ранг среди акций
#4357
Organon & Co., a global pharmaceutical enterprise, is dedicated to developing... Organon & Co., a global pharmaceutical enterprise, is dedicated to developing and delivering a wide array of prescription therapies. Its women's health division features reproductive care products, encompassing birth control and fertility treatments, notably Nexplanon/Implanon, an extended-duration contraceptive. The company's biosimilars collection includes three immune-related medications (Brenzys, Renflexis, Hadlima) and two cancer therapies (Ontruzant, Aybintio). Additionally, Organon provides cardiovascular medications, such as cholesterol-reducing drugs (Zetia, Ezetrol, Vytorin, Inegy, Rosuzet, Zocor) and treatments for high blood pressure (Cozaar, Hyzaar). Their respiratory product line addresses asthma symptoms with brands like Singulair, Dulera, Zenhale, and Asmanex, and manages seasonal allergies through Singulair, Nasonex, Clarinex, and Aerius. Furthermore, their offerings extend to dermatological care (Diprosone, Elocon), bone strengthening (Fosamax), and non-narcotic pain relief (Arcoxia, Diprospan, Celestone). The portfolio also comprises Proscar for treating symptomatic benign prostatic hyperplasia and Propecia for combating male pattern hair loss. The company's products are primarily distributed to pharmaceutical wholesalers, retailers, medical facilities, government entities, and various managed healthcare organizations, including health maintenance organizations and pharmacy benefit managers. Organon & Co. was established in 2020 and is headquartered in Jersey City, New Jersey.
Цена акции
$13.76
Рыночная капитализация
$3.61B
Изменение (1 день)
0.07%
Изменение (1 год)
48.86%
Страна
US
Торговля Organon & Co. (OGN)
Категория
Healthcare
Количество находящихся в обращении акций Organon & Co. (OGN)
Количество акций в обращении на June 2026: 262.61M
Согласно последним финансовым отчетам и цене акций Organon & Co., текущее количество акций в обращении составляет 262.61M. На конец December 2024 у компании было 257.05M акций в обращении. Количество акций в обращении обычно зависит от сплитов и обратного выкупа акций.
История количества акций в обращении Organon & Co. (OGN) с 2017 по 2026
Акции в обращении на конец каждого года
| Год | Акции в обращении | Изменить |
|---|---|---|
| 2026 (TTM) | 262.61M | 1.20% |
| 2025 | 259.50M | 0.95% |
| 2024 | 257.05M | 0.71% |
| 2023 | 255.24M | 0.46% |
| 2022 | 254.08M | 0.21% |
| 2021 | 253.55M | 0.01% |
| 2020 | 253.52M | 0.15% |
| 2019 | 253.13M | 0.00% |
| 2018 | 253.13M | 0.00% |
| 2017 | 253.13M | 0.00% |
Акции в обращении у аналогичных компаний или конкурентов
| Компания | Акции в обращении | Разница | Страна |
|---|---|---|---|
| 892.40M | 239.82% |
US
|
|
| 2.45B | 832.01% |
US
|
|
| 1.77B | 574.38% |
US
|
|
| 0.00 | -100.00% |
US
|
|
| 796.00M | 203.11% |
CH
|
